Technical Analysis for CBIO - Catalyst Inc.

Grade Last Price % Change Price Change
grade B 9.87 -1.89% -0.19
CBIO closed down 1.89 percent on Thursday, December 13, 2018, on 1.55 times normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CBIO trend table...

Date Alert Name Type % Chg
Dec 13 50 DMA Resistance Bearish 0.00%
Dec 13 Multiple of Ten Bearish Other 0.00%
Dec 13 BB Squeeze Ended Range Expansion 0.00%
Dec 13 Below Lower BB Weakness 0.00%
Dec 13 Down 3 Days in a Row Weakness 0.00%
Dec 13 Lower Bollinger Band Touch Weakness 0.00%
Dec 13 Oversold Stochastic Weakness 0.00%
Dec 12 50 DMA Resistance Bearish -1.89%
Dec 12 Bollinger Band Squeeze Range Contraction -1.89%
Dec 12 Stochastic Reached Oversold Weakness -1.89%

Older signals for CBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Catalyst Biosciences, Inc., a biopharmaceutical company, focuses on discovering and developing novel biopharmaceutical products based on engineered human proteases. The company designs its proteases to promote hemostasis and to prevent inflammation. Its pipeline of protease therapeutics include CB 813d/PF-05280602, an engineered Factor VIIa drug candidate that completed a Phase 1 clinical trial evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity. The company's pre-clinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of hemophilia B inhibitor patients; and an engineered Factor Xa for hemophilia and the control of bleeding in non-hemophilia patients. It also develops factor C3 for the prevention of renal delayed graft function and the treatment of dry age-related macular degeneration. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
Is CBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.0
52 Week Low 8.6
Average Volume 171,955
200-Day Moving Average 16.3813
50-Day Moving Average 10.2314
20-Day Moving Average 10.491
10-Day Moving Average 10.32
Average True Range 0.5934
ADX 17.91
+DI 12.096
-DI 20.1536
Chandelier Exit (Long, 3 ATRs ) 9.5098
Chandelier Exit (Short, 3 ATRs ) 11.5902
Upper Bollinger Band 11.1095
Lower Bollinger Band 9.8725
Percent B (%b) 0.0
BandWidth 11.791059
MACD Line -0.0649
MACD Signal Line 0.0305
MACD Histogram -0.0954
Fundamentals Value
Market Cap 42.53 Million
Num Shares 4.31 Million
EPS -14.07
Price-to-Earnings (P/E) Ratio -0.70
Price-to-Sales 35.66
Price-to-Book 0.66
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.62
Resistance 3 (R3) 10.68 10.50 10.50
Resistance 2 (R2) 10.50 10.31 10.47 10.45
Resistance 1 (R1) 10.18 10.19 10.09 10.12 10.41
Pivot Point 10.00 10.00 9.95 9.97 10.00
Support 1 (S1) 9.68 9.81 9.59 9.62 9.33
Support 2 (S2) 9.50 9.69 9.47 9.29
Support 3 (S3) 9.18 9.50 9.25
Support 4 (S4) 9.12